Related Experiment Videos
Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple
Marta Murcia1, Antonio Morreale, Angel R Ortiz
1Department of Physiology and Biophysics, Mount Sinai School of Medicine, One Gustave L. Levy Place, P.O. Box 1218, New York, New York 10029, USA.
Journal of Medicinal Chemistry
|October 13, 2006
Summary
This study introduces an enhanced 3D-QSAR method to predict drug affinity and selectivity for multiple protein targets. The new approach accurately models interactions with thrombin, trypsin, and factor Xa, improving drug design strategies.
Area of Science:
- Computational Chemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Quantitative Structure-Activity Relationship (QSAR) models typically focus on a single receptor.
- Predicting both drug affinity and selectivity across related targets remains a challenge.
- Existing methods struggle to account for subtle differences in binding sites among homologous proteins.
Purpose of the Study:
- To extend comparative binding energy analysis for deriving multi-target 3D-QSAR models.
- To develop a unified model that simultaneously predicts affinity and selectivity for structurally related receptors.
- To investigate the key interactions driving selectivity for thrombin, trypsin, and factor Xa.
Main Methods:
- Incorporation of multiple structurally related receptors into the QSAR model's X-matrix.
- Application of the extended technique to a series of 88 3-amidinophenylalanines.
- Analysis of binding to thrombin, trypsin, and factor Xa (fXa) using 202 protein-ligand complexes.
Main Results:
- A single predictive regression model was generated for all three receptors with a Q(2) of 0.689.
- Ligand occupancy of key binding pockets (D-site, P-site, S1-site rim) correlates with affinity.
- Thrombin's unique 60-loop enhances P-site interactions, conferring specificity; D-site occupancy favors fXa inhibition; negative charge density near position 88 is crucial for thrombin recognition.
Conclusions:
- The extended 3D-QSAR approach successfully integrates affinity and selectivity prediction for multiple targets.
- Specific binding site features, like thrombin's 60-loop and Lys insertion, dictate selectivity.
- The model provides valuable insights for designing selective inhibitors targeting thrombin, trypsin, and fXa.
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...